Potential Improvements in the Pre-emergency Department Care for Cancer Patients (OVERSEE-I)

Erasmus University logo

Erasmus University

Status

Enrolling

Conditions

Emergencies
Cancer

Treatments

Behavioral: Emergency department cancer patients interview

Study type

Observational

Funder types

Other

Identifiers

NCT05974787
10841 (Other Identifier)

Details and patient eligibility

About

The goal of this single center prospective cross-sectional study is to identify the facilitators and barriers in the course of the disease that starts when symptoms first arise until patients with solid and hematologic malignancies arrive in the emergency department (ED). The main question it aims to answer are: Is there a potential relation between the lag-time and the ED length of stay (LOS) and the chance of admission. Participants will be asked to participate in a one-time interview, that focusses on the pre-admission process.

Full description

The goal of this single center prospective cross-sectional study is to identify the facilitators and barriers in the course of the disease that starts when symptoms first arise until patients with solid and hematologic malignancies arrive in the emergency department (ED). The main question it aims to answer are: Is there a potential relation between the lag-time and the emergency department length of stay and the chance of admission. Participants will be asked to participate in a one-time interview, that focusses on the pre-admission process. The interview focuses on several parts of the (pre-)admission process: The first part is regarding the timeline that led to an ED visit. The investigators will establish, when and which symptoms were first detected. The second part are regarding the number and type of health care workers that were contacted before visiting the ED. The third part will be about the actions that were taken before the ED visit.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
  • Presented at or admitted from the emergency department for the oncology, hematology, neuro- or lung-oncology clinical unit.
  • Awake and conscious.
  • Possible to answer questions within 48 hours after presentation at the emergency department (ED).

Exclusion criteria

  • <18 years old
  • Only received a surgical intervention as cancer treatment
  • Admitted to the ED for the surgical department
  • Not willing or able to give written informed consent

Trial design

75 participants in 1 patient group

Cancer patients
Description:
All adult patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months admitted to the emergency department of the Erasmus Medical Center for the oncology, hematology, lung- and neuro-oncology medical unit are eligible for inclusion.
Treatment:
Behavioral: Emergency department cancer patients interview

Trial contacts and locations

0

Loading...

Central trial contact

Jason den Duijn

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems